Shopping Cart 0
Cart Subtotal
AED 0

Global Drug Repurposing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

Scope of the Report:

This report focuses on the Drug Repurposing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.

The worldwide market for Drug Repurposing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Astellas Pharma

Biovista

Novartis

AbbVie

Pfizer

Allergan

NuMedii

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oncology

CNS Diseases

Neurodegenerative Diseases

Others

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Others

There are 15 Chapters to deeply display the global Drug Repurposing market.

Chapter 1, to describe Drug Repurposing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drug Repurposing, with sales, revenue, and price of Drug Repurposing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug Repurposing, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Drug Repurposing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Drug Repurposing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Drug Repurposing Introduction

1.2 Market Analysis by Type

1.2.1 Oncology

1.2.2 CNS Diseases

1.2.3 Neurodegenerative Diseases

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Ambulatory Surgical Centers

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Astellas Pharma

2.1.1 Business Overview

2.1.2 Drug Repurposing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Astellas Pharma Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Biovista

2.2.1 Business Overview

2.2.2 Drug Repurposing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Biovista Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Drug Repurposing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 AbbVie

2.4.1 Business Overview

2.4.2 Drug Repurposing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AbbVie Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Drug Repurposing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allergan

2.6.1 Business Overview

2.6.2 Drug Repurposing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allergan Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 NuMedii

2.7.1 Business Overview

2.7.2 Drug Repurposing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NuMedii Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drug Repurposing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Drug Repurposing Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Drug Repurposing Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Drug Repurposing Manufacturer Market Share in 2017

3.3.2 Top 6 Drug Repurposing Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Drug Repurposing Market Analysis by Regions

4.1 Global Drug Repurposing Sales, Revenue and Market Share by Regions

4.1.1 Global Drug Repurposing Sales and Market Share by Regions (2013-2018)

4.1.2 Global Drug Repurposing Revenue and Market Share by Regions (2013-2018)

4.2 North America Drug Repurposing Sales and Growth Rate (2013-2018)

4.3 Europe Drug Repurposing Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Drug Repurposing Sales and Growth Rate (2013-2018)

4.5 South America Drug Repurposing Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Drug Repurposing Sales and Growth Rate (2013-2018)

5 North America Drug Repurposing by Countries

5.1 North America Drug Repurposing Sales, Revenue and Market Share by Countries

5.1.1 North America Drug Repurposing Sales and Market Share by Countries (2013-2018)

5.1.2 North America Drug Repurposing Revenue and Market Share by Countries (2013-2018)

5.2 United States Drug Repurposing Sales and Growth Rate (2013-2018)

5.3 Canada Drug Repurposing Sales and Growth Rate (2013-2018)

5.4 Mexico Drug Repurposing Sales and Growth Rate (2013-2018)

6 Europe Drug Repurposing by Countries

6.1 Europe Drug Repurposing Sales, Revenue and Market Share by Countries

6.1.1 Europe Drug Repurposing Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Drug Repurposing Revenue and Market Share by Countries (2013-2018)

6.2 Germany Drug Repurposing Sales and Growth Rate (2013-2018)

6.3 UK Drug Repurposing Sales and Growth Rate (2013-2018)

6.4 France Drug Repurposing Sales and Growth Rate (2013-2018)

6.5 Russia Drug Repurposing Sales and Growth Rate (2013-2018)

6.6 Italy Drug Repurposing Sales and Growth Rate (2013-2018)

7 Asia-Pacific Drug Repurposing by Countries

7.1 Asia-Pacific Drug Repurposing Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Drug Repurposing Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Drug Repurposing Revenue and Market Share by Countries (2013-2018)

7.2 China Drug Repurposing Sales and Growth Rate (2013-2018)

7.3 Japan Drug Repurposing Sales and Growth Rate (2013-2018)

7.4 Korea Drug Repurposing Sales and Growth Rate (2013-2018)

7.5 India Drug Repurposing Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Drug Repurposing Sales and Growth Rate (2013-2018)

8 South America Drug Repurposing by Countries

8.1 South America Drug Repurposing Sales, Revenue and Market Share by Countries

8.1.1 South America Drug Repurposing Sales and Market Share by Countries (2013-2018)

8.1.2 South America Drug Repurposing Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Drug Repurposing Sales and Growth Rate (2013-2018)

8.3 Argentina Drug Repurposing Sales and Growth Rate (2013-2018)

8.4 Colombia Drug Repurposing Sales and Growth Rate (2013-2018)

9 Middle East and Africa Drug Repurposing by Countries

9.1 Middle East and Africa Drug Repurposing Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Drug Repurposing Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Drug Repurposing Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Drug Repurposing Sales and Growth Rate (2013-2018)

9.3 UAE Drug Repurposing Sales and Growth Rate (2013-2018)

9.4 Egypt Drug Repurposing Sales and Growth Rate (2013-2018)

9.5 Nigeria Drug Repurposing Sales and Growth Rate (2013-2018)

9.6 South Africa Drug Repurposing Sales and Growth Rate (2013-2018)

10 Global Drug Repurposing Market Segment by Type

10.1 Global Drug Repurposing Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Drug Repurposing Sales and Market Share by Type (2013-2018)

10.1.2 Global Drug Repurposing Revenue and Market Share by Type (2013-2018)

10.2 Oncology Sales Growth and Price

10.2.1 Global Oncology Sales Growth (2013-2018)

10.2.2 Global Oncology Price (2013-2018)

10.3 CNS Diseases Sales Growth and Price

10.3.1 Global CNS Diseases Sales Growth (2013-2018)

10.3.2 Global CNS Diseases Price (2013-2018)

10.4 Neurodegenerative Diseases Sales Growth and Price

10.4.1 Global Neurodegenerative Diseases Sales Growth (2013-2018)

10.4.2 Global Neurodegenerative Diseases Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Drug Repurposing Market Segment by Application

11.1 Global Drug Repurposing Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Ambulatory Surgical Centers Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Drug Repurposing Market Forecast (2018-2023)

12.1 Global Drug Repurposing Sales, Revenue and Growth Rate (2018-2023)

12.2 Drug Repurposing Market Forecast by Regions (2018-2023)

12.2.1 North America Drug Repurposing Market Forecast (2018-2023)

12.2.2 Europe Drug Repurposing Market Forecast (2018-2023)

12.2.3 Asia-Pacific Drug Repurposing Market Forecast (2018-2023)

12.2.4 South America Drug Repurposing Market Forecast (2018-2023)

12.2.5 Middle East and Africa Drug Repurposing Market Forecast (2018-2023)

12.3 Drug Repurposing Market Forecast by Type (2018-2023)

12.3.1 Global Drug Repurposing Sales Forecast by Type (2018-2023)

12.3.2 Global Drug Repurposing Market Share Forecast by Type (2018-2023)

12.4 Drug Repurposing Market Forecast by Application (2018-2023)

12.4.1 Global Drug Repurposing Sales Forecast by Application (2018-2023)

12.4.2 Global Drug Repurposing Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Drug Repurposing Picture

Table Product Specifications of Drug Repurposing

Figure Global Sales Market Share of Drug Repurposing by Types in 2017

Table Drug Repurposing Types for Major Manufacturers

Figure Oncology Picture

Figure CNS Diseases Picture

Figure Neurodegenerative Diseases Picture

Figure Others Picture

Figure Drug Repurposing Sales Market Share by Applications in 2017

Figure Hospitals Picture

Figure Ambulatory Surgical Centers Picture

Figure Others Picture

Figure United States Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure France Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure UK Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure China Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure India Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Table Astellas Pharma Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Drug Repurposing Type and Applications

Table Astellas Pharma Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biovista Basic Information, Manufacturing Base and Competitors

Table Biovista Drug Repurposing Type and Applications

Table Biovista Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Drug Repurposing Type and Applications

Table Novartis Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Drug Repurposing Type and Applications

Table AbbVie Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Drug Repurposing Type and Applications

Table Pfizer Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Drug Repurposing Type and Applications

Table Allergan Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table NuMedii Basic Information, Manufacturing Base and Competitors

Table NuMedii Drug Repurposing Type and Applications

Table NuMedii Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Drug Repurposing Sales by Manufacturer (2016-2017)

Figure Global Drug Repurposing Sales Market Share by Manufacturer in 2016

Figure Global Drug Repurposing Sales Market Share by Manufacturer in 2017

Table Global Drug Repurposing Revenue by Manufacturer (2016-2017)

Figure Global Drug Repurposing Revenue Market Share by Manufacturer in 2016

Figure Global Drug Repurposing Revenue Market Share by Manufacturer in 2017

Figure Top 3 Drug Repurposing Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Drug Repurposing Manufacturer (Revenue) Market Share in 2017

Figure Global Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Global Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Global Drug Repurposing Sales by Regions (2013-2018)

Table Global Drug Repurposing Sales Market Share by Regions (2013-2018)

Table Global Drug Repurposing Revenue by Regions (2013-2018)

Figure Global Drug Repurposing Revenue Market Share by Regions in 2013

Figure Global Drug Repurposing Revenue Market Share by Regions in 2017

Figure North America Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Europe Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drug Repurposing Sales and Growth Rate (2013-2018)

Figure South America Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drug Repurposing Sales and Growth Rate (2013-2018)

Figure North America Drug Repurposing Revenue and Growth Rate (2013-2018)

Table North America Drug Repurposing Sales by Countries (2013-2018)

Table North America Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure North America Drug Repurposing Sales Market Share by Countries in 2013

Figure North America Drug Repurposing Sales Market Share by Countries in 2017

Table North America Drug Repurposing Revenue by Countries (2013-2018)

Table North America Drug Repurposing Revenue Market Share by Countries (2013-2018)

Figure North America Drug Repurposing Revenue Market Share by Countries in 2013

Figure North America Drug Repurposing Revenue Market Share by Countries in 2017

Figure United States Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Canada Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Mexico Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Europe Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Europe Drug Repurposing Sales by Countries (2013-2018)

Table Europe Drug Repurposing Sales Market Share by Countries (2013-2018)

Table Europe Drug Repurposing Revenue by Countries (2013-2018)

Figure Europe Drug Repurposing Revenue Market Share by Countries in 2016

Figure Europe Drug Repurposing Revenue Market Share by Countries in 2017

Figure Germany Drug Repurposing Sales and Growth Rate (2013-2018)

Figure UK Drug Repurposing Sales and Growth Rate (2013-2018)

Figure France Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Russia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Italy Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Drug Repurposing Sales by Countries (2013-2018)

Table Asia-Pacific Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Drug Repurposing Sales Market Share by Countries 2017

Table Asia-Pacific Drug Repurposing Revenue by Countries (2013-2018)

Figure Asia-Pacific Drug Repurposing Revenue Market Share by Countries 2017

Figure China Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Japan Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Korea Drug Repurposing Sales and Growth Rate (2013-2018)

Figure India Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Southeast Asia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure South America Drug Repurposing Revenue and Growth Rate (2013-2018)

Table South America Drug Repurposing Sales by Countries (2013-2018)

Table South America Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure South America Drug Repurposing Sales Market Share by Countries in 2017

Table South America Drug Repurposing Revenue by Countries (2013-2018)

Table South America Drug Repurposing Revenue Market Share by Countries (2013-2018)

Figure South America Drug Repurposing Revenue Market Share by Countries in 2017

Figure Brazil Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Argentina Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Colombia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Drug Repurposing Sales by Countries (2013-2018)

Table Middle East and Africa Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Drug Repurposing Sales Market Share by Countries in 2017

Table Middle East and Africa Drug Repurposing Revenue by Countries (2013-2018)

Table Middle East and Africa Drug Repurposing Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2013

Figure Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2017

Figure Saudi Arabia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure UAE Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Egypt Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Nigeria Drug Repurposing Sales and Growth Rate (2013-2018)

Figure South Africa Drug Repurposing Sales and Growth Rate (2013-2018)

Table Global Drug Repurposing Sales by Type (2013-2018)

Table Global Drug Repurposing Sales Share by Type (2013-2018)

Table Global Drug Repurposing Revenue by Type (2013-2018)

Table Global Drug Repurposing Revenue Share by Type (2013-2018)

Figure Global Oncology Sales Growth (2013-2018)

Figure Global Oncology Price (2013-2018)

Figure Global CNS Diseases Sales Growth (2013-2018)

Figure Global CNS Diseases Price (2013-2018)

Figure Global Neurodegenerative Diseases Sales Growth (2013-2018)

Figure Global Neurodegenerative Diseases Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Drug Repurposing Sales by Application (2013-2018)

Table Global Drug Repurposing Sales Share by Application (2013-2018)

Figure Global Ambulatory Surgical Centers Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Drug Repurposing Sales, Revenue and Growth Rate (2018-2023)

Table Global Drug Repurposing Sales Forecast by Regions (2018-2023)

Table Global Drug Repurposing Market Share Forecast by Regions (2018-2023)

Figure North America Sales Drug Repurposing Market Forecast (2018-2023)

Figure Europe Sales Drug Repurposing Market Forecast (2018-2023)

Figure Asia-Pacific Sales Drug Repurposing Market Forecast (2018-2023)

Figure South America Sales Drug Repurposing Market Forecast (2018-2023)

Figure Middle East and Africa Sales Drug Repurposing Market Forecast (2018-2023)

Table Global Drug Repurposing Sales Forecast by Type (2018-2023)

Table Global Drug Repurposing Market Share Forecast by Type (2018-2023)

Table Global Drug Repurposing Sales Forecast by Application (2018-2023)

Table Global Drug Repurposing Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Astellas Pharma

Biovista

Novartis

AbbVie

Pfizer

Allergan

NuMedii

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

Scope of the Report:

This report focuses on the Drug Repurposing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.

The worldwide market for Drug Repurposing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Astellas Pharma

Biovista

Novartis

AbbVie

Pfizer

Allergan

NuMedii

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oncology

CNS Diseases

Neurodegenerative Diseases

Others

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Centers

Others

There are 15 Chapters to deeply display the global Drug Repurposing market.

Chapter 1, to describe Drug Repurposing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drug Repurposing, with sales, revenue, and price of Drug Repurposing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug Repurposing, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Drug Repurposing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Drug Repurposing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Drug Repurposing Introduction

1.2 Market Analysis by Type

1.2.1 Oncology

1.2.2 CNS Diseases

1.2.3 Neurodegenerative Diseases

1.2.4 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Ambulatory Surgical Centers

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Astellas Pharma

2.1.1 Business Overview

2.1.2 Drug Repurposing Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Astellas Pharma Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Biovista

2.2.1 Business Overview

2.2.2 Drug Repurposing Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Biovista Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Drug Repurposing Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 AbbVie

2.4.1 Business Overview

2.4.2 Drug Repurposing Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AbbVie Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Drug Repurposing Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Allergan

2.6.1 Business Overview

2.6.2 Drug Repurposing Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Allergan Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 NuMedii

2.7.1 Business Overview

2.7.2 Drug Repurposing Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NuMedii Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Drug Repurposing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Drug Repurposing Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Drug Repurposing Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Drug Repurposing Manufacturer Market Share in 2017

3.3.2 Top 6 Drug Repurposing Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Drug Repurposing Market Analysis by Regions

4.1 Global Drug Repurposing Sales, Revenue and Market Share by Regions

4.1.1 Global Drug Repurposing Sales and Market Share by Regions (2013-2018)

4.1.2 Global Drug Repurposing Revenue and Market Share by Regions (2013-2018)

4.2 North America Drug Repurposing Sales and Growth Rate (2013-2018)

4.3 Europe Drug Repurposing Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Drug Repurposing Sales and Growth Rate (2013-2018)

4.5 South America Drug Repurposing Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Drug Repurposing Sales and Growth Rate (2013-2018)

5 North America Drug Repurposing by Countries

5.1 North America Drug Repurposing Sales, Revenue and Market Share by Countries

5.1.1 North America Drug Repurposing Sales and Market Share by Countries (2013-2018)

5.1.2 North America Drug Repurposing Revenue and Market Share by Countries (2013-2018)

5.2 United States Drug Repurposing Sales and Growth Rate (2013-2018)

5.3 Canada Drug Repurposing Sales and Growth Rate (2013-2018)

5.4 Mexico Drug Repurposing Sales and Growth Rate (2013-2018)

6 Europe Drug Repurposing by Countries

6.1 Europe Drug Repurposing Sales, Revenue and Market Share by Countries

6.1.1 Europe Drug Repurposing Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Drug Repurposing Revenue and Market Share by Countries (2013-2018)

6.2 Germany Drug Repurposing Sales and Growth Rate (2013-2018)

6.3 UK Drug Repurposing Sales and Growth Rate (2013-2018)

6.4 France Drug Repurposing Sales and Growth Rate (2013-2018)

6.5 Russia Drug Repurposing Sales and Growth Rate (2013-2018)

6.6 Italy Drug Repurposing Sales and Growth Rate (2013-2018)

7 Asia-Pacific Drug Repurposing by Countries

7.1 Asia-Pacific Drug Repurposing Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Drug Repurposing Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Drug Repurposing Revenue and Market Share by Countries (2013-2018)

7.2 China Drug Repurposing Sales and Growth Rate (2013-2018)

7.3 Japan Drug Repurposing Sales and Growth Rate (2013-2018)

7.4 Korea Drug Repurposing Sales and Growth Rate (2013-2018)

7.5 India Drug Repurposing Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Drug Repurposing Sales and Growth Rate (2013-2018)

8 South America Drug Repurposing by Countries

8.1 South America Drug Repurposing Sales, Revenue and Market Share by Countries

8.1.1 South America Drug Repurposing Sales and Market Share by Countries (2013-2018)

8.1.2 South America Drug Repurposing Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Drug Repurposing Sales and Growth Rate (2013-2018)

8.3 Argentina Drug Repurposing Sales and Growth Rate (2013-2018)

8.4 Colombia Drug Repurposing Sales and Growth Rate (2013-2018)

9 Middle East and Africa Drug Repurposing by Countries

9.1 Middle East and Africa Drug Repurposing Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Drug Repurposing Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Drug Repurposing Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Drug Repurposing Sales and Growth Rate (2013-2018)

9.3 UAE Drug Repurposing Sales and Growth Rate (2013-2018)

9.4 Egypt Drug Repurposing Sales and Growth Rate (2013-2018)

9.5 Nigeria Drug Repurposing Sales and Growth Rate (2013-2018)

9.6 South Africa Drug Repurposing Sales and Growth Rate (2013-2018)

10 Global Drug Repurposing Market Segment by Type

10.1 Global Drug Repurposing Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Drug Repurposing Sales and Market Share by Type (2013-2018)

10.1.2 Global Drug Repurposing Revenue and Market Share by Type (2013-2018)

10.2 Oncology Sales Growth and Price

10.2.1 Global Oncology Sales Growth (2013-2018)

10.2.2 Global Oncology Price (2013-2018)

10.3 CNS Diseases Sales Growth and Price

10.3.1 Global CNS Diseases Sales Growth (2013-2018)

10.3.2 Global CNS Diseases Price (2013-2018)

10.4 Neurodegenerative Diseases Sales Growth and Price

10.4.1 Global Neurodegenerative Diseases Sales Growth (2013-2018)

10.4.2 Global Neurodegenerative Diseases Price (2013-2018)

10.5 Others Sales Growth and Price

10.5.1 Global Others Sales Growth (2013-2018)

10.5.2 Global Others Price (2013-2018)

11 Global Drug Repurposing Market Segment by Application

11.1 Global Drug Repurposing Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Ambulatory Surgical Centers Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Drug Repurposing Market Forecast (2018-2023)

12.1 Global Drug Repurposing Sales, Revenue and Growth Rate (2018-2023)

12.2 Drug Repurposing Market Forecast by Regions (2018-2023)

12.2.1 North America Drug Repurposing Market Forecast (2018-2023)

12.2.2 Europe Drug Repurposing Market Forecast (2018-2023)

12.2.3 Asia-Pacific Drug Repurposing Market Forecast (2018-2023)

12.2.4 South America Drug Repurposing Market Forecast (2018-2023)

12.2.5 Middle East and Africa Drug Repurposing Market Forecast (2018-2023)

12.3 Drug Repurposing Market Forecast by Type (2018-2023)

12.3.1 Global Drug Repurposing Sales Forecast by Type (2018-2023)

12.3.2 Global Drug Repurposing Market Share Forecast by Type (2018-2023)

12.4 Drug Repurposing Market Forecast by Application (2018-2023)

12.4.1 Global Drug Repurposing Sales Forecast by Application (2018-2023)

12.4.2 Global Drug Repurposing Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Drug Repurposing Picture

Table Product Specifications of Drug Repurposing

Figure Global Sales Market Share of Drug Repurposing by Types in 2017

Table Drug Repurposing Types for Major Manufacturers

Figure Oncology Picture

Figure CNS Diseases Picture

Figure Neurodegenerative Diseases Picture

Figure Others Picture

Figure Drug Repurposing Sales Market Share by Applications in 2017

Figure Hospitals Picture

Figure Ambulatory Surgical Centers Picture

Figure Others Picture

Figure United States Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure France Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure UK Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure China Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure India Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)

Table Astellas Pharma Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Drug Repurposing Type and Applications

Table Astellas Pharma Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Biovista Basic Information, Manufacturing Base and Competitors

Table Biovista Drug Repurposing Type and Applications

Table Biovista Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Drug Repurposing Type and Applications

Table Novartis Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AbbVie Basic Information, Manufacturing Base and Competitors

Table AbbVie Drug Repurposing Type and Applications

Table AbbVie Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Drug Repurposing Type and Applications

Table Pfizer Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Allergan Basic Information, Manufacturing Base and Competitors

Table Allergan Drug Repurposing Type and Applications

Table Allergan Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table NuMedii Basic Information, Manufacturing Base and Competitors

Table NuMedii Drug Repurposing Type and Applications

Table NuMedii Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Drug Repurposing Sales by Manufacturer (2016-2017)

Figure Global Drug Repurposing Sales Market Share by Manufacturer in 2016

Figure Global Drug Repurposing Sales Market Share by Manufacturer in 2017

Table Global Drug Repurposing Revenue by Manufacturer (2016-2017)

Figure Global Drug Repurposing Revenue Market Share by Manufacturer in 2016

Figure Global Drug Repurposing Revenue Market Share by Manufacturer in 2017

Figure Top 3 Drug Repurposing Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Drug Repurposing Manufacturer (Revenue) Market Share in 2017

Figure Global Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Global Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Global Drug Repurposing Sales by Regions (2013-2018)

Table Global Drug Repurposing Sales Market Share by Regions (2013-2018)

Table Global Drug Repurposing Revenue by Regions (2013-2018)

Figure Global Drug Repurposing Revenue Market Share by Regions in 2013

Figure Global Drug Repurposing Revenue Market Share by Regions in 2017

Figure North America Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Europe Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drug Repurposing Sales and Growth Rate (2013-2018)

Figure South America Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drug Repurposing Sales and Growth Rate (2013-2018)

Figure North America Drug Repurposing Revenue and Growth Rate (2013-2018)

Table North America Drug Repurposing Sales by Countries (2013-2018)

Table North America Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure North America Drug Repurposing Sales Market Share by Countries in 2013

Figure North America Drug Repurposing Sales Market Share by Countries in 2017

Table North America Drug Repurposing Revenue by Countries (2013-2018)

Table North America Drug Repurposing Revenue Market Share by Countries (2013-2018)

Figure North America Drug Repurposing Revenue Market Share by Countries in 2013

Figure North America Drug Repurposing Revenue Market Share by Countries in 2017

Figure United States Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Canada Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Mexico Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Europe Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Europe Drug Repurposing Sales by Countries (2013-2018)

Table Europe Drug Repurposing Sales Market Share by Countries (2013-2018)

Table Europe Drug Repurposing Revenue by Countries (2013-2018)

Figure Europe Drug Repurposing Revenue Market Share by Countries in 2016

Figure Europe Drug Repurposing Revenue Market Share by Countries in 2017

Figure Germany Drug Repurposing Sales and Growth Rate (2013-2018)

Figure UK Drug Repurposing Sales and Growth Rate (2013-2018)

Figure France Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Russia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Italy Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Drug Repurposing Sales by Countries (2013-2018)

Table Asia-Pacific Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Drug Repurposing Sales Market Share by Countries 2017

Table Asia-Pacific Drug Repurposing Revenue by Countries (2013-2018)

Figure Asia-Pacific Drug Repurposing Revenue Market Share by Countries 2017

Figure China Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Japan Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Korea Drug Repurposing Sales and Growth Rate (2013-2018)

Figure India Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Southeast Asia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure South America Drug Repurposing Revenue and Growth Rate (2013-2018)

Table South America Drug Repurposing Sales by Countries (2013-2018)

Table South America Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure South America Drug Repurposing Sales Market Share by Countries in 2017

Table South America Drug Repurposing Revenue by Countries (2013-2018)

Table South America Drug Repurposing Revenue Market Share by Countries (2013-2018)

Figure South America Drug Repurposing Revenue Market Share by Countries in 2017

Figure Brazil Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Argentina Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Colombia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Drug Repurposing Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Drug Repurposing Sales by Countries (2013-2018)

Table Middle East and Africa Drug Repurposing Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Drug Repurposing Sales Market Share by Countries in 2017

Table Middle East and Africa Drug Repurposing Revenue by Countries (2013-2018)

Table Middle East and Africa Drug Repurposing Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2013

Figure Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2017

Figure Saudi Arabia Drug Repurposing Sales and Growth Rate (2013-2018)

Figure UAE Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Egypt Drug Repurposing Sales and Growth Rate (2013-2018)

Figure Nigeria Drug Repurposing Sales and Growth Rate (2013-2018)

Figure South Africa Drug Repurposing Sales and Growth Rate (2013-2018)

Table Global Drug Repurposing Sales by Type (2013-2018)

Table Global Drug Repurposing Sales Share by Type (2013-2018)

Table Global Drug Repurposing Revenue by Type (2013-2018)

Table Global Drug Repurposing Revenue Share by Type (2013-2018)

Figure Global Oncology Sales Growth (2013-2018)

Figure Global Oncology Price (2013-2018)

Figure Global CNS Diseases Sales Growth (2013-2018)

Figure Global CNS Diseases Price (2013-2018)

Figure Global Neurodegenerative Diseases Sales Growth (2013-2018)

Figure Global Neurodegenerative Diseases Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Drug Repurposing Sales by Application (2013-2018)

Table Global Drug Repurposing Sales Share by Application (2013-2018)

Figure Global Ambulatory Surgical Centers Sales Growth (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Drug Repurposing Sales, Revenue and Growth Rate (2018-2023)

Table Global Drug Repurposing Sales Forecast by Regions (2018-2023)

Table Global Drug Repurposing Market Share Forecast by Regions (2018-2023)

Figure North America Sales Drug Repurposing Market Forecast (2018-2023)

Figure Europe Sales Drug Repurposing Market Forecast (2018-2023)

Figure Asia-Pacific Sales Drug Repurposing Market Forecast (2018-2023)

Figure South America Sales Drug Repurposing Market Forecast (2018-2023)

Figure Middle East and Africa Sales Drug Repurposing Market Forecast (2018-2023)

Table Global Drug Repurposing Sales Forecast by Type (2018-2023)

Table Global Drug Repurposing Market Share Forecast by Type (2018-2023)

Table Global Drug Repurposing Sales Forecast by Application (2018-2023)

Table Global Drug Repurposing Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Astellas Pharma

Biovista

Novartis

AbbVie

Pfizer

Allergan

NuMedii